Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/22/1999CN1047598C Dammarane-type saponin ginseng lowhydric alcohol derivative and prepn. method
12/22/1999CN1047595C Prepn. method of aminocoumaran derivatives
12/22/1999CN1047594C Piperazinyl- and piperidinyl-cyclohexanols, its prepn. and application
12/22/1999CN1047525C 治疗癌症的药物 Cancer drugs
12/22/1999CN1047521C Medicinal preparation for prevention and treatment dermatophyte
12/22/1999CN1047520C Medicine of lowering blood lipid levels
12/22/1999CN1047519C Nifedipine injection
12/22/1999CN1047518C Method of preparing oral pharmaceutical compositions
12/22/1999CA2274741A1 Use of a compound having an affinity for the mitochondrial benzodiazepine receptor in cancer therapy
12/21/1999US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists
12/21/1999US6005116 Isoxazole compounds useful for the prophylaxis or treatment of nervous diseases
12/21/1999US6005115 Forms A and B of N-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl ]thio]ethyl]ami no]methylene]-4-bromo-benzenesulfonamide
12/21/1999US6005103 Pyrone derivatives as protease inhibitors and antiviral agents
12/21/1999US6005099 For immunomodulators, antitumor agents, and components of vaccines with reduced endotoxicity
12/21/1999US6005098 Nucleoside derivative which can be administered with 5-fluorouracil to enhance antitumor activity
12/21/1999US6005096 For oligonucleotides that are modified to enhance the binding affinity and to bear detectable labels; for diagnostic use
12/21/1999US6005095 Antisense agents; antitumor agents
12/21/1999US6005091 Nucleic acids encoding immunoglobulin domains
12/21/1999US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999US6005020 Bioresorbable compositions for implantable prostheses
12/21/1999US6005010 Cardiovascular disorders, antiarrhythmia agents and antiischemic agents
12/21/1999US6005009 Method of inhibiting fibrosis with pyridoxal benzoyl hydrazone and analogs thereof
12/21/1999US6005005 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl) propionic acid
12/21/1999US6005003 Osteoporosis treatment
12/21/1999US6005002 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production
12/21/1999US6005001 Pharmaceutical composition
12/21/1999US6005000 5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use therefor
12/21/1999US6004998 Flavonoid 6,8-dibromochrysin
12/21/1999US6004996 Tetrahydrolipstatin containing compositions
12/21/1999US6004995 Macrolide compound 0406
12/21/1999US6004994 Antiinflammatory agents, cyclooxygenase inhibitors and analgesics
12/21/1999US6004993 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/21/1999US6004991 Compounds for cosmetics with enantiomorphs
12/21/1999US6004988 Carboxylic acid derivatives, their preparation and their use
12/21/1999US6004987 Use of ligands which are specific for RXR receptors
12/21/1999US6004986 Brains and antiischemic agents
12/21/1999US6004985 Thio acid derived monocylic N-heterocyclics as anticoagulants
12/21/1999US6004983 Analgesics; antiinflammatory, antiarthritic and antidiabetic agents
12/21/1999US6004979 Angiotensin ii inhibitors; 4-((carboxy)aryloxy)-quinoline derivatives
12/21/1999US6004978 Methods of treating cancer with aromatic nitro and nitroso compounds and their metabolites
12/21/1999US6004975 Anxiolytic agents with side effect reduction
12/21/1999US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999US6004973 Pharmaceutical compositions comprising rafamycin coprecipitates
12/21/1999US6004972 Therapeutic process for the treatment of the pathologies of type II diabetes
12/21/1999US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods
12/21/1999US6004970 Administering with nicotine and drug enhancer
12/21/1999US6004969 Administering with drug penetration enhancer
12/21/1999US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy
12/21/1999US6004967 Psoriasis treatment with quinazoline compounds
12/21/1999US6004966 Use of xanthine oxidase inhibitors as anti-ischaemic agents
12/21/1999US6004965 Endothelin inhibitors; hypotensive agents; cardiovascular disorders
12/21/1999US6004964 Administering amide or sulfonamide derivative; analgesics
12/21/1999US6004963 Tumor necrosis factor release inhibitors; immunomodulators
12/21/1999US6004961 1,4-disubstituted piperazines
12/21/1999US6004958 Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
12/21/1999US6004953 Administering synergistic mixture of ascorbic acid and cobalt or iron phthalo- or naphthalocyanine complex; side effect reduction; anticarcinogenic agents; catalysis
12/21/1999US6004951 Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
12/21/1999US6004948 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II
12/21/1999US6004946 Administering 2-(hydroxyphosphinylmethyl)-pentanedioic acid derivatives; treating nervous system disorders
12/21/1999US6004945 Use of adenosine compounds to relieve pain
12/21/1999US6004939 Methods for modulation and inhibition of telomerase
12/21/1999US6004938 Inositolglycans having insulin-like action
12/21/1999US6004931 Method for inhibiting growth hormone action
12/21/1999US6004813 Il-6 activity inhibitor
12/21/1999US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines
12/21/1999US6004799 Recombinant live feline immunodeficiency virus and proviral DNA vaccines
12/21/1999US6004764 Screening methods for potential therapeutic agents which regulate the growth of m. tuberculosis; method for identifying genes of m. tuberculosis which are regulated by a sigma factor of m. tuberculosis
12/21/1999US6004742 Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
12/21/1999US6004741 Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
12/21/1999US6004585 Granular composition of a triazine compound
12/21/1999US6004582 For immediate delivery of a first active agent followed by a monitored, continuous, controlled and/or retarded delivery of a second active agent which is the same or different as the first active agent; time-release agents
12/21/1999US6004579 Aging inhibition; wound healing agent; preserving organs; treating dermatological conditions such as wrinkling, sagging, baldness, psoriasis
12/21/1999US6004578 For enhancing the percutaneous absorption of drugs when administered to a body surface or membrane
12/21/1999US6004575 Use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability
12/21/1999US6004565 Administering fingolimod hydrochloride
12/21/1999US6004553 Inhibitors of tumor necrosis factor receptor associated factor-(traf) mediated signal transduction; use in screening assays and as pharmaceuticals
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
12/21/1999US6004537 Inhaler comprising container of pressurized aerosol solution comprising budesonide, formoterol, fluoroalkane propellant, cosolvent present in amount to dissolve or solubilize mixture
12/21/1999US6004354 IceA gene and related methods
12/21/1999US6004299 Injection vessel and solution-enclosed injection vessel in use thereof
12/21/1999CA2150552C Antithrombotic
12/21/1999CA2135850C Esculetin derivatives, and method for manufacture thereof, use thereof, and pharmaceutical composition
12/21/1999CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/21/1999CA2044280C Vitamin d analogues
12/21/1999CA2035653C Neuroprotective 3-piperidino-4-hydrosychroman derivatives
12/21/1999CA2026974C 3-aroyl-2-oxindole-1-carboximides
12/21/1999CA2003422C Quinuclidines, their use as medicaments and processes for their preparation
12/21/1999CA2001325C Stabile parenteral solution of 2-phenyl-1,2-benzisoselenazol-3(2h)-one and process for producing the same
12/21/1999CA2001171C Method for controlling and/or lowering serum triglyceride and/or cholesterol levels in mammals
12/21/1999CA1340856C N-phosphonylmethoxyalkyl pyrimidines and purines and therapeutic application thereof
12/17/1999CA2274943A1 Compositions for the treatment and prevention of inflammatory diseases of the gastrointestinal tract and methods and uses thereof
12/17/1999CA2235420A1 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/16/1999WO1999065228A2 Pharmaceutical combination used to compensate for a testosterone deficiency while protecting the prostate
12/16/1999WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999WO1999064615A1 Formulations for electroporation
12/16/1999WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999WO1999064594A2 Genes and gene expression products that are differentially regulated in prostate cancer
12/16/1999WO1999064588A1 TGFβ RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES
12/16/1999WO1999064578A1 Stabilized transient gene expression
1 ... 6392 6393 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 6412 ... 7860